DNM1L and ischemia: Mdivi-1 is often described as a DRP1 inhibitor and has been utilized in the context of neuronal injury to attenuate traumatic brain injury-induced cell death [25], protect against glutamate excitotoxicity and oxygen-glucose deprivation [26], and reduce cerebral damage caused by ischemia/reperfusion injury [27].